Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

203 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Intensity Modulated Radiotherapy (IMRT) With Carbon Ion Boost in the Multimodal Treatment of Salivary Duct Carcinoma.
Adeberg S, Windisch P, Ehret F, Baur M, Akbaba S, Held T, Bernhardt D, Haefner MF, Krauss J, Kargus S, Freudlsperger C, Plinkert P, Flechtenmacher C, Herfarth K, Debus J, Rieken S. Adeberg S, et al. Among authors: rieken s. Front Oncol. 2019 Dec 20;9:1420. doi: 10.3389/fonc.2019.01420. eCollection 2019. Front Oncol. 2019. PMID: 31921675 Free PMC article.
Long-term outcome after radiotherapy in patients with atypical and malignant meningiomas--clinical results in 85 patients treated in a single institution leading to optimized guidelines for early radiation therapy.
Adeberg S, Hartmann C, Welzel T, Rieken S, Habermehl D, von Deimling A, Debus J, Combs SE. Adeberg S, et al. Among authors: rieken s. Int J Radiat Oncol Biol Phys. 2012 Jul 1;83(3):859-64. doi: 10.1016/j.ijrobp.2011.08.010. Epub 2011 Dec 2. Int J Radiat Oncol Biol Phys. 2012. PMID: 22137023
Chemoradiation in patients with unresectable extrahepatic and hilar cholangiocarcinoma or at high risk for disease recurrence after resection : Analysis of treatment efficacy and failure in patients receiving postoperative or primary chemoradiation.
Habermehl D, Lindel K, Rieken S, Haase K, Goeppert B, Büchler MW, Schirmacher P, Welzel T, Debus J, Combs SE. Habermehl D, et al. Among authors: rieken s. Strahlenther Onkol. 2012 Sep;188(9):795-801. doi: 10.1007/s00066-012-0099-y. Epub 2012 Apr 13. Strahlenther Onkol. 2012. PMID: 22526232 Clinical Trial.
203 results